194 related articles for article (PubMed ID: 16152798)
1. [Polymorphic gene markers of lipid metabolism are associated with diabetic nephropathy in patients with type 1 diabetes mellitus].
Iakunina NIu; Shestakova MV; Voron'ko OE; Vikulova OK; Sevost'ianov KV; Chugunova LA; Shamkhalova MSh; Dedov II; Nosikov VV
Genetika; 2005 Jul; 41(7):931-7. PubMed ID: 16152798
[TBL] [Abstract][Full Text] [Related]
2. [Association of polymorphic markers of lipid metabolism genes with diabetic polyneuropathy in type 1 diabetes mellitus].
Voron'ko OE; Iakunina NIu; Strokov IA; Lavrova IN; Nosikov VV
Mol Biol (Mosk); 2005; 39(2):230-4. PubMed ID: 15856946
[TBL] [Abstract][Full Text] [Related]
3. Apo E gene polymorphism on development of diabetic nephropathy.
Ilhan N; Kahraman N; Seçkin D; Ilhan N; Colak R
Cell Biochem Funct; 2007; 25(5):527-32. PubMed ID: 16933203
[TBL] [Abstract][Full Text] [Related]
4. The presence of apolipoprotein epsilon4 and epsilon2 alleles augments the risk of coronary artery disease in type 2 diabetic patients.
Vaisi-Raygani A; Rahimi Z; Nomani H; Tavilani H; Pourmotabbed T
Clin Biochem; 2007 Oct; 40(15):1150-6. PubMed ID: 17689519
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E polymorphism and expression in type 2 diabetic patients with nephropathy: clinicopathological correlation.
Guan J; Zhao HL; Baum L; Sui Y; He L; Wong H; Lai FM; Tong PC; Chan JC
Nephrol Dial Transplant; 2009 Jun; 24(6):1889-95. PubMed ID: 19218599
[TBL] [Abstract][Full Text] [Related]
6. [Polymorphisms Ser447Ter of lipoprotein-lipase gene, Cys112Arg and Arg158Cys of apolipoprotein E gene in patients with obesity].
Kirillova OO; Vorozhko IV; Gapparova KM; Chekhonina IuG; Sentsova TB; Tutel'ian VA
Vopr Pitan; 2013; 82(4):4-9. PubMed ID: 24340925
[TBL] [Abstract][Full Text] [Related]
7. Association of lipoprotein lipase S447X, apolipoprotein E exon 4, and apoC3 -455T>C polymorphisms on the susceptibility to diabetic nephropathy.
Ng MC; Baum L; So WY; Lam VK; Wang Y; Poon E; Tomlinson B; Cheng S; Lindpaintner K; Chan JC
Clin Genet; 2006 Jul; 70(1):20-8. PubMed ID: 16813599
[TBL] [Abstract][Full Text] [Related]
8. Higher frequency of apolipoprotein E2 allele in type 2 diabetic patients with nephropathy in Taiwan.
Hsieh MC; Lin SR; Yang YC; Chen HC; Lin JN; Shin SJ
J Nephrol; 2002; 15(4):368-73. PubMed ID: 12243365
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E genetic polymorphism influence the susceptibility to nephropathy in type 2 diabetes patients.
Atageldiyeva KK; Nemr R; Echtay A; Racoubian E; Sarray S; Almawi WY
Gene; 2019 Oct; 715():144011. PubMed ID: 31357022
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E gene and early age-related maculopathy: the Atherosclerosis Risk in Communities Study.
Wong TY; Shankar A; Klein R; Bray MS; Couper DJ; Klein BE; Sharrett AR; Folsom AR
Ophthalmology; 2006 Feb; 113(2):255-9. PubMed ID: 16406547
[TBL] [Abstract][Full Text] [Related]
11. Association of apolipoprotein E genotypes with serum lipid profiles in a healthy population of Taiwan.
Lin SK; Kao JT; Tsai SM; Tsai LY; Lin MN; Lai CJ; Zhong WL
Ann Clin Lab Sci; 2004; 34(4):443-8. PubMed ID: 15648787
[TBL] [Abstract][Full Text] [Related]
12. [Relation of apolipoprotein E polymorphism to clinically diagnosed fatty liver disease].
Lee DM; Lee SO; Mun BS; Ahn HS; Park HY; Lee HS; Kim DG
Taehan Kan Hakhoe Chi; 2002 Dec; 8(4):355-62. PubMed ID: 12506239
[TBL] [Abstract][Full Text] [Related]
13. Plasma level and genetic variation of apolipoprotein E in patients with lipoprotein glomerulopathy.
Zhang B; Liu ZH; Zeng CH; Zheng JM; Chen HP; Zhou H; Li LS
Chin Med J (Engl); 2005 Apr; 118(7):555-60. PubMed ID: 15820086
[TBL] [Abstract][Full Text] [Related]
14. [A search for association between the polymorphic markers of PON1 and PON2 genes and diabetic nephropathy in patients with type I diabetes mellitus].
Voron'ko OE; Iakunina NIu; Shestakova MV; Zotova EV; Chugunova EV; Shamkhalova MSh; Vikulova OK; Debabov VG; Dedov VG; Nosikov VV
Genetika; 2005 Jun; 41(6):844-9. PubMed ID: 16080611
[TBL] [Abstract][Full Text] [Related]
15. Apo E genotype, diabetes, and peripheral arterial disease in older men: the Honolulu Asia-aging study.
Resnick HE; Rodriguez B; Havlik R; Ferrucci L; Foley D; Curb JD; Harris TB
Genet Epidemiol; 2000 Jul; 19(1):52-63. PubMed ID: 10861896
[TBL] [Abstract][Full Text] [Related]
16. [Association of polymorphous markers Pro72Arg and C(-594)CC OF TP53 gene with diabetic polyneuropathy in patients with type 1 diabetes mellitus living in Moscow].
Spitsina EV; Iakunina NIu; Chudakova DA; Nikitin AG; Svetlova GN; Soluianova TN; Strokov IA; Nosikov VV
Mol Biol (Mosk); 2007; 41(6):989-93. PubMed ID: 18318116
[TBL] [Abstract][Full Text] [Related]
17. Association of aldose reductase gene Z+2 polymorphism with reduced susceptibility to diabetic nephropathy in Caucasian Type 1 diabetic patients.
Lajer M; Tarnow L; Fleckner J; Hansen BV; Edwards DG; Parving HH; Boel E
Diabet Med; 2004 Aug; 21(8):867-73. PubMed ID: 15270790
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E4 reduces risk of diabetic nephropathy in patients with NIDDM.
Kimura H; Suzuki Y; Gejyo F; Karasawa R; Miyazaki R; Suzuki S; Arakawa M
Am J Kidney Dis; 1998 Apr; 31(4):666-73. PubMed ID: 9531184
[TBL] [Abstract][Full Text] [Related]
19. Relationship between Apolipoprotein E polymorphism and nephropathy in type-2 diabetic patients.
Leiva E; Mujica V; Elematore I; Orrego R; Díaz G; Prieto M; Arredondo M
Diabetes Res Clin Pract; 2007 Nov; 78(2):196-201. PubMed ID: 17481771
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E polymorphism in type 2 diabetic patients of Talca, Chile.
Leiva E; Mujica V; Orrego R; Prieto M; Arredondo M
Diabetes Res Clin Pract; 2005 Jun; 68(3):244-9. PubMed ID: 15936467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
